
Topic 1 |
Clinical application of cancer biomarkers: Blood/Serum-based molecular markers | ||
| Chairs: | Fred SWEEP (EU) & Herbert FRITSCHE (USA) | ||
Topic 2 |
Clinical application of cancer biomarkers: Tissue-based molecular markers | ||
| Chairs: | Sabine TEJPAR (EU) & Elise KOHN (USA) | ||
Topic 3 |
Ethical, legal and regularory issues in biomarker research | ||
| Chairs: | Fatima CARDOSO (EU) & John JESSUP (USA) | ||
Topic 4 |
Pharmacogenomics & pharmacogenetics | ||
| Chairs: | Godefridus J. PETERS (EU) & Geoffrey LIU (USA) | ||
Topic 5 |
New assessment criteria for clinico-genomic trials | ||
| Chairs: | Roger STUPP (EU) & Larry RUBINSTEIN (USA) | ||
Topic 6 |
Can we obtain the most from the least tissue? | ||
| Chairs: | Manfred SCHMITT (EU) & David RIMM (USA) | ||
Topic 7 |
Cancer stem cells: ready for the clinic? | ||
| Chairs: | Maria Grazia DAIDONE (EU) & Catherine O'BRIEN (CA) | ||
Topic 8 |
Successful clinico-genomic trials: How to run them? | ||
| Chairs: | Nadia HARBECK (EU) & Bruce JOHNSON (USA) | ||
EORTC is partially supported by the Belgian National Lottery and by the Belgian Federal Science Policy Office